Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function: a secondary analysis from the ADVANCE trial in South Africa

Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function: a secondary analysis from the ADVANCE trial in South Africa

Abstract Introduction Recent evidence has raised questions about whether newer HIV treatment regimens, including dolutegravir (DTG) and tenofovir alafenamide (TAF), are associated with increases in blood pressure (BP). Methods We assessed changes in BP by treatment regimen and evaluated the relative...

Descripción completa

Detalles Bibliográficos
Autores principales: Jennifer Manne‐Goehler, June Fabian, Simiso Sokhela, Godspower Akpomiemie, Nicholas Rahim, Samanta Tresha Lalla‐Edward, Alana T. Brennan, Mark J. Siedner, Andrew Hill, Willem Daniel Francois Venter
Formato: Artículo
Lenguaje:English
Publicado: Wiley 2024-07-01
Colección:Journal of the International AIDS Society
Materias:
hypertension
HIV
dolutegravir
tenofovir alafenamide
obesity
kidney function
Acceso en línea:https://doi.org/10.1002/jia2.26268

Internet

https://doi.org/10.1002/jia2.26268

Ejemplares similares